Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) rose 5.3% during mid-day trading on Wednesday . The stock traded as high as $1.41 and last traded at $1.40. Approximately 151,027 shares were traded during mid-day trading, an increase of 125% from the average daily volume of 67,097 shares. The stock had previously closed at $1.33.
Cardiol Therapeutics Price Performance
The firm’s fifty day moving average price is $1.36 and its 200-day moving average price is $1.76.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Read More
- Five stocks we like better than Cardiol Therapeutics
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Must-Have ETFs Set to Dominate This Quarter
- Transportation Stocks Investing
- Seeking Stability? These 3 Stocks Offer Strong Potential
- The 3 Best Retail Stocks to Shop for in August
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
